Abstract
The authors provide evidence-based guidance on treating human brucellosis, and discuss the future clinical trials that would help address the controversies surrounding treatment.
Publication types
-
Historical Article
-
Practice Guideline
MeSH terms
-
Animals
-
Anti-Bacterial Agents / history
-
Anti-Bacterial Agents / therapeutic use*
-
Biomedical Research / standards
-
Brucellosis / classification
-
Brucellosis / drug therapy*
-
Brucellosis / history
-
Brucellosis / microbiology
-
Developing Countries*
-
Doxycycline / therapeutic use
-
Drug Combinations
-
Drug Resistance, Microbial
-
Drug Therapy, Combination
-
Fluoroquinolones / therapeutic use
-
Gentamicins / therapeutic use
-
Global Health*
-
Guideline Adherence
-
History, 21st Century
-
Humans
-
Recurrence
-
Rifampin / therapeutic use
-
Streptomycin / therapeutic use
-
Terminology as Topic
-
Treatment Outcome
-
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
-
World Health Organization
Substances
-
Anti-Bacterial Agents
-
Drug Combinations
-
Fluoroquinolones
-
Gentamicins
-
Trimethoprim, Sulfamethoxazole Drug Combination
-
Doxycycline
-
Rifampin
-
Streptomycin